SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-011098
Filing Date
2024-02-07
Accepted
2024-02-07 16:15:27
Documents
16
Period of Report
2024-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193020-8k_intensity.htm   iXBRL 8-K 29331
2 INCENTIVE COMPENSATION PLAN ea193020ex10-1_intensity.htm EX-10.1 41878
6 GRAPHIC ex10-1_001.jpg GRAPHIC 1758
  Complete submission text file 0001213900-24-011098.txt   257783

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ints-20240206.xsd EX-101.SCH 3054
4 XBRL LABEL FILE ints-20240206_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ints-20240206_pre.xml EX-101.PRE 22385
17 EXTRACTED XBRL INSTANCE DOCUMENT ea193020-8k_intensity_htm.xml XML 3734
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

IRS No.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 24604479
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)